ORIC Pharmaceuticals Reports Inducement Grantsunder Nasdaq Listing Rule 5635

ORIC Stock  USD 10.42  0.35  3.25%   
About 62% of Oric Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Oric Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Oric Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Oric Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2025 -- ORIC Pharmaceuticals, Inc. , a clinical stage oncology company...

Read at globenewswire.com
Macroaxis News: globenewswire.com
  

Oric Pharmaceuticals Fundamental Analysis

We analyze Oric Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oric Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oric Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Oric Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Oric Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oric Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Oric Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Oric Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Oric Pharmaceuticals Related Equities

ELVNEnliven Therapeutics   2.77   
0%
26.0%
CELCCelcuity LLC   1.96   
0%
18.0%
IMRXImmuneering Corp   1.57   
0%
15.0%
SEERSeer   1.27   
0%
12.0%
HOWLWerewolf Therapeutics   0.75   
0%
7.0%
MLYSMineralys Therapeutics,   0.29   
0%
2.0%
EWTXEdgewise Therapeutics   0.07   
0%
1.0%
PHVSPharvaris   0.73   
7.0%
0%
MOLNMolecular Partners   1.34   
12.0%
0%
PMVPPmv Pharmaceuticals   1.39   
13.0%
0%
ANTXAN2 Therapeutics   2.56   
24.0%
0%
ANEBAnebulo Pharmaceuticals   3.14   
30.0%
0%
CGEMCullinan Oncology   3.83   
36.0%
0%
CCCCC4 Therapeutics   5.71   
54.0%
0%
PEPGPepGen   10.42   
100.0%
0%

Complementary Tools for Oric Stock analysis

When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges